Literature DB >> 2993650

Inversion and circularization of the varicella-zoster virus genome.

P R Kinchington, W C Reinhold, T A Casey, S E Straus, J Hay, W T Ruyechan.   

Abstract

The genome of varicella-zoster virus (VZV) is a linear, double-stranded molecule of DNA composed of a long (L) region covalently linked to a short (S) region. The S region is capable of inverting relative to a fixed orientation of the L region, giving rise to two equimolar populations. We have investigated other forms of the VZV genome which are present in infected cells and packaged into nucleocapsids. That a small proportion of nucleocapsid DNA molecules also possess inverted L regions has been verified by the identification of submolar restriction fragments corresponding to novel joints and novel ends generated by such an inversion. The presence of circular molecules has been investigated by agarose gel electrophoresis. Bands corresponding to circular forms were present in small amounts in both VZV-infected cell DNA and nucleocapsid DNA. Southern blot analysis verified that these bands contained VZV sequences. We therefore conclude that the VZV genome may occasionally contain an inverted L region or exist in a circular configuration.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993650      PMCID: PMC252505     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA.

Authors:  E S Mocarski; B Roizman
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

2.  The internal organization of the varicella-zoster virus genome.

Authors:  D H Gilden; Y Shtram; A Friedmann; M Wellish; M Devlin; N Fraser; Y Becker
Journal:  J Gen Virol       Date:  1982-06       Impact factor: 3.891

3.  Molecular cloning of the varicella-zoster virus genome and derivation of six restriction endonuclease maps.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

4.  Variation in the structure of varicella-zoster virus DNA.

Authors:  J R Ecker; L Kudler; R W Hyman
Journal:  Intervirology       Date:  1984       Impact factor: 1.763

5.  Structure of nonintegrated, circular Herpesvirus saimiri and Herpesvirus ateles genomes in tumor cell lines and in vitro-transformed cells.

Authors:  C Kaschka-Dierich; F J Werner; I Bauer; B Fleckenstein
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

6.  Inversion of the two segments of the herpes simplex virus genome in intertypic recombinants.

Authors:  A J Davison; N M Wilkie
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

7.  Circular forms of viral DNA in Marek's disease virus-transformed lymphoblastoid cells.

Authors:  H J Rziha; B Bauer
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Molecular cloning and physical mapping of varicella-zoster virus DNA.

Authors:  S E Straus; J Owens; W T Ruyechan; H E Takiff; T A Casey; G F Vande Woude; J Hay
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Varicella zoster virus DNA exists as two isomers.

Authors:  J R Ecker; R W Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

10.  DNA sequence of the US component of the varicella-zoster virus genome.

Authors:  A J Davison
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  16 in total

1.  Identification and characterization of a varicella-zoster virus DNA-binding protein by using antisera directed against a predicted synthetic oligopeptide.

Authors:  P R Kinchington; G Inchauspe; J H Subak-Sharpe; F Robey; J Hay; W T Ruyechan
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Relationship of herpes simplex virus genome configuration to productive and persistent infections.

Authors:  Sara A Jackson; Neal A DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

3.  Variation of R1 repeated sequence present in open reading frame 11 of varicella-zoster virus strains.

Authors:  H Kinoshita; R Hondo; F Taguchi; Y Yogo
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C.

Authors:  P R Kinchington; J Remenick; J M Ostrove; S E Straus; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

5.  Circularization of the herpes simplex virus type 1 genome upon lytic infection.

Authors:  Blair L Strang; Nigel D Stow
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification.

Authors:  Annabel Rector; Ruth Tachezy; Marc Van Ranst
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

8.  Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts.

Authors:  Stefan L Oliver; Leigh Zerboni; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol Methods       Date:  2008-09-24       Impact factor: 2.014

9.  Low-level inversion of the L component of pseudorabies virus is not dependent on sequence homology.

Authors:  G F Rall; S Kupershmidt; X Q Lu; T C Mettenleiter; T Ben-Porat
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Genome variation among varicella-zoster virus isolates derived from different individuals and from the same individuals.

Authors:  R Hondo; Y Yogo; T Kurata; Y Aoyama
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.